Pages that link to "Q57374971"
Jump to navigation
Jump to search
The following pages link to The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia (Q57374971):
Displaying 50 items.
- Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids (Q26996516) (← links)
- ZAP-70 in B cell malignancies (Q28279902) (← links)
- Functional and prognostic role of ZAP-70 in chronic lymphocytic leukaemia (Q28282822) (← links)
- Lipoprotein lipase in chronic lymphocytic leukemia: function and prognostic implications. (Q30248557) (← links)
- Genomic data integration in chronic lymphocytic leukemia. (Q31147488) (← links)
- SAGE analysis demonstrates increased expression of TOSO contributing to Fas-mediated resistance in CLL. (Q33330596) (← links)
- Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia (Q33587644) (← links)
- High expression of lymphocyte-activation gene 3 (LAG3) in chronic lymphocytic leukemia cells is associated with unmutated immunoglobulin variable heavy chain region (IGHV) gene and reduced treatment-free survival (Q33813862) (← links)
- Chromatin accessibility maps of chronic lymphocytic leukaemia identify subtype-specific epigenome signatures and transcription regulatory networks (Q33862792) (← links)
- Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia (Q33886052) (← links)
- ADAM and ADAMTS family proteins and their role in the colorectal cancer etiopathogenesis (Q34049378) (← links)
- Human endogenous retrovirus np9 gene is over expressed in chronic lymphocytic leukemia patients (Q34091109) (← links)
- How I treat CLL up front (Q34137158) (← links)
- Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression (Q34253142) (← links)
- The use of microarray technologies in clinical oncology (Q34496896) (← links)
- The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia (Q34542102) (← links)
- LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia (Q35143479) (← links)
- Expression and role of RIP140/NRIP1 in chronic lymphocytic leukemia (Q35162589) (← links)
- Characterization of autosomal copy-number variation in African Americans: the HyperGEN Study. (Q35591673) (← links)
- Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells (Q35611369) (← links)
- Developing Molecular Signatures for Chronic Lymphocytic Leukemia (Q35653850) (← links)
- Regulatory network reconstruction reveals genes with prognostic value for chronic lymphocytic leukemia (Q35852820) (← links)
- Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technology (Q35988140) (← links)
- Lipoprotein lipase is frequently overexpressed or translocated in cervical squamous cell carcinoma and promotes invasiveness through the non-catalytic C terminus (Q36166804) (← links)
- New molecular markers in resistant B-CLL. (Q36497411) (← links)
- Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia (Q36564932) (← links)
- CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes (Q36579130) (← links)
- Metabolism pathways in chronic lymphocytic leukemia (Q36693111) (← links)
- Lipoprotein lipase: a new prognostic factor in chronic lymphocytic leukaemia (Q36942667) (← links)
- Cryptochrome-1 expression: a new prognostic marker in B-cell chronic lymphocytic leukemia (Q37082690) (← links)
- Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline (Q37340635) (← links)
- Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia (Q37552790) (← links)
- RNA-based markers as prognostic factors in chronic lymphocytic leukemia (Q37978344) (← links)
- Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand? (Q38088354) (← links)
- Analysis of chronic lymphotic leukemia transcriptomic profile: differences between molecular subgroups (Q38511275) (← links)
- Fatty Acids and Breast Cancer: Make Them on Site or Have Them Delivered (Q38722530) (← links)
- Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia. (Q39273067) (← links)
- High expression of MZB1 predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature (Q39512567) (← links)
- Search for an aetiological virus candidate in chronic lymphocytic leukaemia by extensive transcriptome analysis (Q40029728) (← links)
- Biologic prognostic markers and their application in clinical trials and management of chronic lymphocytic leukaemia patients (Q40138593) (← links)
- Selection of reference genes for quantitative polymerase chain reaction studies in purified B cells from B cell chronic lymphocytic leukaemia patients (Q44215157) (← links)
- Lipoprotein lipase expression in unmutated CLL patients is the consequence of a demethylation process induced by the microenvironment (Q45384341) (← links)
- Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia (Q46375237) (← links)
- Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells (Q46850551) (← links)
- Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia: New Insights into Leukemic Progression (Q48047258) (← links)
- Methylation status regulates lipoprotein lipase expression in chronic lymphocytic leukemia (Q51044690) (← links)
- Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation. (Q51579239) (← links)
- Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status (Q51979921) (← links)
- Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia. (Q53036715) (← links)
- COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status. (Q53098391) (← links)